Prescriber decision-making on antithrombotic therapy after endovascular intervention for peripheral artery disease: a protocol for a discrete choice experiment.
Alison Y ZhuRobert TangSaissan RajendranHamid HajianSarah Joy AitkenPublished in: BMJ open (2024)
Ethics approval was obtained from the University of Sydney Human Ethics committee (2023/474). The results of this study will be published in peer-reviewed journals and presented at national vascular surgical conferences. These results will be used to improve understanding how clinicians make prescribing decisions and to inform future strategy to enhance guideline-directed prescribing.
Keyphrases
- peripheral artery disease
- decision making
- primary care
- randomized controlled trial
- public health
- endothelial cells
- big data
- atrial fibrillation
- adverse drug
- palliative care
- meta analyses
- quality improvement
- current status
- induced pluripotent stem cells
- global health
- systematic review
- cell therapy
- replacement therapy